Back to results
US 2024/0124850 A1Published application
Auxotrophic Cells for Virus Production and Compositions and Methods of Making
AssigneeShape Therapeutics Inc.
InventorsKenneth Prentice, Lindsey Nicole Deis Huffman, Sandhya Pande
Life of this patent
Estimating the term…
Abstract
Disclosed herein are cells and cell lines that are selected for retention of at least two exogenous nucleic acid constructs using a single selective pressure. Also disclosed herein are compositions and methods for generating recombinant cells and cell lines using a single selective pressure.
Claims62
A composition comprising:
- a) a first exogenous nucleic acid construct comprising:
- i) a first polynucleotide of interest;
- and
- ii) a sequence encoding an N-terminal fragment of a functional selectable protein fused in-frame to a sequence encoding an N-terminal fragment of an intein;
- and
- b) a second exogenous nucleic acid construct comprising:
- i) a second polynucleotide of interest;
- and
- ii) a sequence encoding a C-terminal fragment of the intein fused in-frame to a sequence encoding a C-terminal fragment of the functional selectable protein;
- wherein, when expressed, the N-terminal fragment of the functional selectable protein and the C-terminal fragment of the selectable protein are joined together to form the functional selectable protein by the N-terminal fragment of the intein and the C-terminal fragment of the intein,
- wherein the functional selectable protein is selected from the group consisting of glutamine synthetase (GS), phenylalanine hydroxylase (PAH), dihydrofolate reductase (DHFR), and thymidylate synthase (TYMS), and
- wherein the first and second nucleic acid constructs are exogenous to an eukaryotic host cell in which they are introduced.
9 more elements
Dependencies are inferred from the claim text.